Post-Transplant Chimerism Patterns in Patients with Myelodysplastic Syndromes and Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation at the John Theurer Cancer Center Read more
Dynamic Changes in Pre- and Post-Transplant NGS MRD Status For Prediction of the Allogeneic Stem Cell Transplant Outcome in Patients with AML Read more
Multicenter Study to Evaluate Incidence and Outcomes of Cardiovascular Events in Adult Reduced Intensity Conditioning Allogeneic Hematopoietic Cellular Transplantation Recipients Receiving Post-Transplantation Cyclophosphamide Read more
A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing Lower Respiratory Tract Complications in Patients with Hematologic Malignancies and Recipients of Hematopoietic Stem Cell Transplantation (HSCT) with Documented Viral Infections with Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) Read more
A Phase 2 Study of Fludarabine and Intermediate Dose Total Body Irradiation (800 cGy) Followed by Post-Transplant Cyclophosphamide in Patients Aged 18-65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies Read more
